Background and Purpose—The role of aspirin plus clopidogrel (A+ C) therapy compared
with aspirin monotherapy in patients presenting with acute ischemic stroke (IS) or transient …

Background and Purpose—Optimal antiplatelet therapy after an ischemic stroke or transient
ischemic attack while on aspirin is uncertain. We, therefore, conducted a systematic review …

Background: Antiplatelet agents are the mainstay for secondary prevention of non-
cardioembolic stroke. This systematic review examined the safety and efficacy of short …

Importance Dual antiplatelet therapy has been demonstrated to be superior to single
antiplatelet in reducing recurrent stroke among patients with transient ischemic attack or …

Background: Aspirin plus clopidogrel (A+ C) may be more effective than aspirin only (AO)
acutely after TIA and minor stroke, but the risk of bleeding in the acute phase is uncertain …

Importance Results show the short-term risk of hemorrhage in treating patients with acute
transient ischemic attack (TIA) or minor acute ischemic stroke (AIS) with clopidogrel plus …

Aim. Though combination of clopidogrel added to aspirin has been compared to aspirin
alone in patients with stroke or transient ischemic attack, limited data exists on the relative …

Background The Clopidogrel for High Atherothrombotic Risk and Ischaemic Stabilisation,
Management and Avoidance (CHARISMA) trial reported no statistically significant benefit of …

Recurrent stroke is common immediately following a transient ischemic attack (TIA) or
ischemic stroke. Dual antiplatelet therapy (DAPT) with clopidogrel and aspirin may provide …

Background Combination antiplatelet therapy with clopidogrel and aspirin may reduce the
rate of recurrent stroke during the first 3 months after a minor ischemic stroke or transient …